FDA Allows Yumanity to Test Single Doses of YTX-7739
The U.S. Food and Drug Administration (FDA) has issued a partial clinical hold in response to an application by…
Articles by Marisa Wexler, MS
Alpha-synuclein Plays ‘Critical’ Role in Immune Responses to Inflammation
The protein alpha-synuclein, which has a well-established role in the development of Parkinson’s disease, is necessary for the body…
MJFF $5.2M Grant to ASU Supports Stem Cell Trial, Neuron Research
The Michael J. Fox Foundation has awarded $5.2 million to scientists at Arizona State University (ASU) to support three…
Plant of Indian Medicine Seen to Ease Insomnia, Restless Leg Syndrome
Adding a plant-derived agent called Withania somnifera, used in traditional Ayurvedic medicine and thought to help with disturbed sleep, to the insomnia…
MJFF Awards Grant to Cantabio to Develop Tau-focused Therapy
Cantabio Pharmaceuticals has been awarded a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to…
Value of At-home Care Visits for Advanced Parkinson’s Focus of Trial
A clinical trial in the U.S. is evaluating whether home visits from healthcare providers might improve the quality of life…
Changes in Hand Temperature After Exposure May Aid in Early Diagnosis
Measuring changes in the temperature of the hands after immersion in cold water could be useful in making an early…
Patients in Need of Levodopa Add-on Rate 3 Treatment Classes in Trial
In treating Parkinson’s symptoms that aren’t being adequately controlled by levodopa, monoamine oxidase type B (MAO-B) inhibitors are…
Early Use of Gocovri Could Delay Levodopa-induced Dyskinesia: Study
Early treatment with Gocovri (amantadine) may delay the onset of dyskinesia, the uncontrolled movements that are a common…
Top 10 Parkinson’s Disease Stories of 2021
All through 2021, Parkinson’s News Today brought you coverage of cutting-edge science and developments in treatment related to Parkinson’s disease.